GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (TSE:7733) » Definitions » Change In Payables And Accrued Expense

Olympus (TSE:7733) Change In Payables And Accrued Expense : 円0 Mil (TTM As of Dec. 2023)


View and export this data going back to 1949. Start your Free Trial

What is Olympus Change In Payables And Accrued Expense?

Olympus's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was 円0 Mil. It means Olympus's Accounts Payable & Accrued Expense stayed the same from Sep. 2023 to Dec. 2023 .

Olympus's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2023 was 円0 Mil. It means Olympus's Accounts Payable & Accrued Expense stayed the same from Mar. 2022 to Mar. 2023 .


Olympus Change In Payables And Accrued Expense Historical Data

The historical data trend for Olympus's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Change In Payables And Accrued Expense Chart

Olympus Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Olympus Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Olympus Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olympus Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Olympus's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus (TSE:7733) Business Description

Industry
Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.

Olympus (TSE:7733) Headlines

No Headlines